IPSC – century therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025 [Yahoo! Finance]
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
Century Therapeutics, Inc. (NASDAQ: IPSC) had its price target lowered by analysts at HC Wainwright from $5.00 to $2.00. They now have a "buy" rating on the stock.
Century Therapeutics, Inc. (NASDAQ: IPSC) had its "buy" rating re-affirmed by analysts at Guggenheim.
Century Therapeutics, Inc. (NASDAQ: IPSC) had its price target lowered by analysts at Chardan Capital from $11.00 to $7.00. They now have a "buy" rating on the stock.
Form S-8 Century Therapeutics,
Form 8-K Century Therapeutics, For: Mar 19
Form 10-K Century Therapeutics, For: Dec 31
Form 4 Century Therapeutics, For: Mar 11 Filed by: Cowan Chad
Form 4 Century Therapeutics, For: Mar 10 Filed by: Pfeiffenberger Brent
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.